Skip to main content
. 2012 May 1;18(5):BR167–BR173. doi: 10.12659/MSM.882725

Figure 3.

Figure 3

The valency of mAb-pZNF32-8D9 shown by ELISA. (A) The effects of different concentrations of mAb-pZNF32-8D9 when 1 ng/mL peptide49–63 was coated. (B) The concentration of peptide49–63 detected with 40 ng/mL mAb-pZNF32-8D9.